|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/713 | (2006.01) | ||
| A61P 13/12 | (2006.01) |
| (11) | Number of the document | 2371958 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11170912.7 |
| Date of filing the European patent application | 2007-10-25 | |
| (97) | Date of publication of the European application | 2011-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 854503 P | 2006-10-25 | US | |
| 930493 P | 2007-05-15 | US |
| (72) |
Feinstein, Elena, IL
Kalinski, Hagar, IL
|
| (73) |
Quark Pharmaceuticals, Inc.,
6501 Dumbarton Circle, Fremont, California 94555,
US
|
| (54) | Novel siRNAs and methods of use thereof |
| Novel siRNAs and methods of use thereof |